arrow
S

Sodiomon B. Sirima

groupe de recherche action en sante
H指数:58
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Widespread Variants of the Highly Polymorphic Plasmodium falciparum Vaccine Candidate Antigen MSP2 Across Sub-Saharan Africa

撒哈拉以南非洲广泛存在的恶性疟原虫疫苗候选抗原MSP2的多态性变异体

2026-07-220
OAAI
African-specific genetic loci determine iron status and risk of severe malaria and bacteremia in African children

非洲特异性的遗传位点决定非洲儿童中铁状况以及重症疟疾和菌血症的风险。

2026-04-070
OAAI
Five-Year Experience of the Groupe de Recherche Action en Santé (GRAS) Clinical Laboratory, Burkina Faso, in Participating into an External Proficiency Testing (EPT) Programme

布基纳法索Groupe de Recherche Action en Santé (GRAS)临床实验室参与外部能力验证计划(EPT)五年的经验

2025-12-230
OAAI
A Multiplex Serological Assay to Evaluate the Antibody Responses to a Set of Plasmodium falciparum Antigens and Their Protective Role Against Malaria in Children Aged 1.5 to 12 Years Living in a Highly Seasonal Malaria Transmission Area of Burkina Faso

一种多重血清学检测方法,用于评估对一组 *Plasmodium falciparum* 抗原的抗体反应及其在布基纳法索高度季节性疟疾传播区域中,对1.5至12岁儿童的保护作用。

2025-10-240
OAAI
Safety, Tolerability, and Immunogenicity of the InvaplexAR-Detox Shigella Vaccine Co-Administered with the dmLT Adjuvant in Dutch and Zambian Adults: Study Protocol for a Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Phase Ia/b Clinical Trial
2025-01-080
OAAI
High-resolution African HLA resource uncovers HLA-DRB1 expression effects underlying vaccine response

高分辨率非洲HLA资源揭示了疫苗反应背后的HLA-DRB1表达效应

2024-05-130
OAAI
A randomized first-in-human phase I trial of differentially adjuvanted Pfs48/45 malaria vaccines in Burkinabé adults
2024-04-012
OAAI
Long-Term Clinical Safety of the Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: A Prospective, Multi-Country, Observational Study
2024-02-172
OAAI
Phase 1b randomized, controlled, double-blinded, age de-escalation trial to evaluate the safety, reactogenicity and immunogenicity of BK-SE36/CpG malaria vaccine in Burkinabe healthy adults and children
2023-12-170
OA
Safety and immunogenicity of BK-SE36/CpG malaria vaccine in healthy Burkinabe adults and children: a phase 1b randomised, controlled, double-blinded, age de-escalation trial
2023-10-166
OAAI
Sporozoite immunization: innovative translational science to support the fight against malaria

子孢子预防接种: 支持抗击疟疾的创新转化科学

2023-08-1122
OAAI
Immune response of a two-dose heterologous Ebola vaccine regimen: summary of three African clinical trials using a single validated Filovirus Animal Nonclinical Group enzyme-linked immunosorbent assay in a single accredited laboratory
2023-05-011
OAAI